1. Endometrial Committee David Scott Miller, M.D., F.A.C.O.G., F.A.C.S. Director and Dallas Foundation Chair in Gynecologic Oncology Professor of Obstetrics & Gynecology…

1. PLATINUM COMPOUNDS 9/10/2012 DR. R. RAJKUMAR III YR POST GRADUATEDEPARTMENT OF MEDICAL ONCOLOGY 2. Derivati del platino 3. Sir Kenneth was Chief Medical Officer for Scotland…

Slide 1First-line management of follicular lymphoma: Will induction and maintenance treatment prolong survival? Robert Marcus Department of Haematology, Addenbrooke’s Hospital,…

Slide 1 Optimal Use of Newly Approved Agents – Carfilzomib and Pomalidomide Lymphoma-Myeloma Symposium October 2013 Scottsdale, Arizona Rochester, Minnesota Jacksonville,…

Slide 1 Career Opportunities for PharmDs in the Pharmaceutical Industry: Research & Development Slide 2 Outline Describe the functions and responsibilities performed…

CAPTASA 2009 9th Annual Conference Embassy Suites Lexington, KY January 23, 2009 Detox â Then What? âSeek the company of those who are looking for the truth. Run from those…

Timing of Transplant for Multiple Myeloma Robert Z. Orlowski, Ph.D., M.D. Director, Myeloma Section Professor, Departments of Lymphoma/Myeloma & Experimental Therapeutics…

JB 11-11 2009 Sunitinib in Combination with Docetaxel vs. Docetaxel Alone for the First-line Treatment of Advanced Breast Cancer J Bergh,1 R Greil,2 NL Voytko,3 AN Makhson,4…

Optimal Use of Newly Approved Agents – Carfilzomib and Pomalidomide Lymphoma-Myeloma Symposium October 2013 Joseph Mikhael, MD, MEd, FRCPC, FACP Staff Hematologist, Mayo…

Timing of Transplant for Multiple Myeloma Robert Z. Orlowski, Ph.D., M.D. Director, Myeloma Section Professor, Departments of Lymphoma/Myeloma & Experimental Therapeutics…